Evidence-based Anticancer Materia Medica for Cervical Cancer

  • Tatjana Stanojković
  • Aleksandra Konić-Ristić
  • Teodora Janković
  • Gordana Zdunić
  • Katarina Šavikin
Part of the Evidence-based Anticancer Complementary and Alternative Medicine book series (ACAM, volume 2)


Carcinoma of the cervix is the second most common malignant neoplasia among women, following breast cancer. Approximately 500,000 new cases of cervix cancer are diagnosed worldwide each year. Along with conventional chemotherapeutic or surgery treatment, there is an increased interest in alternative treatment modalities that include complementary and alternative medicine (CAM). In this chapter, we have reviewed the literature related with the herbs, herbal formulations and phytochemical constituents that act specifically inhibiting the neoplasia of the cervix. Large amount of data is available on in vitro anticancer effects of different herbal preparations and isolated bioactive compounds on cervical cancer cells, evaluating the mechanisms that underlie their effects. Turmeric, mistletoe and green tea are representative plants that exert anticancer effects. Despite of large amount of data on in vitro anticancer effects of different herbal preparations and isolated bioactive compounds on cervical cancer cells, only few clinical studies have been performed in humans. Only paclitaxel, irinotecan, and vinorelbine (chemotherapeutic agents of plant origin) have been investigated in an ongoing a Phase III clinical trials or already successfully applied as a part of conventional chemotherapeutic regiments for cervical cancer. The continued popularity of herbal remedies worldwide suggests that evidence-based research in this field, as well as information regarding the potential efficacy and safety of phytochemical constituents in herbs is essential, particularly when CAM is used in combination with other drugs.


Cervical Cancer Cervical Intraepithelial Neoplasia Cervical Cancer Cell Ursolic Acid Curcuma Longa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors acknowledge the gratitude to the Ministry of Science and Technological Development of Serbia for financial support, project No. 46013.


  1. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–398PubMedGoogle Scholar
  2. Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE et al (2003) Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 12:383–390PubMedGoogle Scholar
  3. Ammon HP, Wahl MA (1991) Pharmacology of Curcuma longa. Planta Med 57:1–7PubMedGoogle Scholar
  4. Antonia S, Mule JJ, Weber JS (2004) Current developments of immunotherapy in the clinic. Curr Opin Immunol 16:130–136PubMedGoogle Scholar
  5. Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, Vermeulen NP (2007) Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 235:83–91PubMedGoogle Scholar
  6. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG (2008) Bulten Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. J Obstet Gynecol 111:167–177Google Scholar
  7. Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB (2004) Evidence that activation of nuclear factor-κB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol 67:353–364PubMedGoogle Scholar
  8. Barnes J, Anderson LA, Phillipson DJ (2007) Herbal medicines. Pharmaceutical Press, London/ChicagoGoogle Scholar
  9. Bar-Sela G, Epelbaum R, Schaffer M (2010) Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17:190–197PubMedGoogle Scholar
  10. Beijnen JH, Schellens JH (2004) Drug interactions in oncology. Lancet Oncol 5:489–496PubMedGoogle Scholar
  11. Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P et al (2000) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78:123–129PubMedGoogle Scholar
  12. Bernardi M, D’Intino PE, Trevisani F, Cantelli-Forti G, Raggi MA, Turchetto E et al (1994) Effects of prolonged ingestion of graded doses of liquorice by healthy volunteers. Life Sci 55:863–872PubMedGoogle Scholar
  13. Bhavani Shankar TN, Shantha NV, Ramesh HP (1980) Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol 18:73–75Google Scholar
  14. Blumenthal M, Goldberg A, Brinckmann J (eds) (2000) Herbal medicine: expanded Commission E monographs. Integrative Medicine Communications, AustinGoogle Scholar
  15. Braun L, Cohen M (2007) Herbs & natural supplements: an evidence-based guide. Elsevier Australia, MarrickvilleGoogle Scholar
  16. Brenner DE, Gescher AJ (2005) Cancer chemoprevention: lessons learned and future directions. Br J Cancer 93:735–739PubMedGoogle Scholar
  17. Brignall MS (2001) Prevention and treatment of cancer with indole-3-carbinol. Altern Med Rev 6:580–589PubMedGoogle Scholar
  18. Brinker F (1998) Herb contraindications and drug interactions. Eclectic Medical Publications, SandyGoogle Scholar
  19. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT (2000) An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7:273–282PubMedGoogle Scholar
  20. Bussing A, Stumpf C, Troger W, Schietzel M (2007) Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts. Anticancer Res 27:2903–2910PubMedGoogle Scholar
  21. Cao W, Li XQ, Wang X, Fan HT, Zhang XN, Hou Y et al (2010) A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway. Phytomedicine 17:598–605PubMedGoogle Scholar
  22. Caponigro F, Basile M, De Rosa V, Normanno N (2005) New drugs in cancer therapy. Anticancer Drugs 16:211–221PubMedGoogle Scholar
  23. Cassileth BR (1999) Evaluating complementary and alternative therapies for cancer patients. CA: Canc J Clin 49:362–375Google Scholar
  24. Cassileth BK, Yeung S, Gubili J (2008) Herbs and other botanicals in cancer patient care. Curr Treat Options Oncol 9:109–116PubMedGoogle Scholar
  25. Chainani-Wu N (2003) Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med 9:161–168PubMedGoogle Scholar
  26. Chamberlain TJ (1970) Licorice poisoning, pseudoaldosteronism, heart failure. JAMA 213:343Google Scholar
  27. Chan HT, Chan C, Ho JW (2003a) Inhibition of glycyrrhizic acid on aflatoxin B1-induced cytotoxicity in hepatoma cells. Toxicology 188:211–217PubMedGoogle Scholar
  28. Chan MM, Fong D, Soprano KJ, Holmes WF, Heverling H (2003b) Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 194:63–70PubMedGoogle Scholar
  29. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS et al (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–2900PubMedGoogle Scholar
  30. Chung JH, Choi DH, Choi JS (2009) Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 30:90–93PubMedGoogle Scholar
  31. Conn JW, Rovner DR, Cohen EL (1968) Licorice-induced pseudoaldosteronism. Hypertension, hypokaelemia, aldosteronopenia and suppressed plasma renin activity. JAMA 205:492–496PubMedGoogle Scholar
  32. Correa-Velez I, Clavarino A, Eastwood H (2005) Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 8(5):953–961PubMedGoogle Scholar
  33. Corsi FM, Galgani S, Gasparini C, Giacanelli M, Piazza G (1983) Acute hypokalemic myopathy due to chronic licorice ingestion: report of a case. Ital J Neurol Sci 4:493–497PubMedGoogle Scholar
  34. de Moura MD, de Sousa e Silva J, de Oliveira RA, Diniz MF, Barbosa-Filho JM (2002) Natural products reported as potential inhibitors of uterine cervical neoplasia. Acta Farm Bonaerense 21:67–74Google Scholar
  35. Del Priore G, Gudipudi DK, Montemarano N, Restivo AM, Malanowska-Stega J, Arslan AA (2010) Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol 116:464–467PubMedGoogle Scholar
  36. Duarte-Franco E, Eduardo MD, Franko L (2001) Determinants of patient survival in cervical cancer: an overview. J Gynecol Oncol 6:173–183Google Scholar
  37. Dy G, Bekele L, Hanson L, Furth A, Mandrekar S, Sloan J et al (2004) Complementaty and alternative medicine use by patients enrolled onto Phase I clinical trials. J Clin Oncol 22:4810–4815PubMedGoogle Scholar
  38. Elshaikh M, Ljungman M, Ten Haken R, Lichter AS (2006) Advances in radiation oncology. Annu Rev Med 57:19–31PubMedGoogle Scholar
  39. Eriksson JW, Carlberg B, Hillorn V (1999) Life-threatening ventricular tachycardia due to liquorice-induced hypokalemia. J Intern Med 245:307–310PubMedGoogle Scholar
  40. Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T et al (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 7:25PubMedGoogle Scholar
  41. Farese RV Jr, Biglieri EG, Shackleton CH, Irony I, Gomez-Fontes R (1991) Licorice-induced hypermineralocorticoidism. N Engl J Med 325:1223–1227PubMedGoogle Scholar
  42. Fellmer Ch, Fellmer KE (1966) Nachbehandlung bestrahlter Genitalkarzinome mit dem Viscum-album-Präparat “Iscador”. Krebsarzt 21:174–185Google Scholar
  43. Finall AI, McIntosh SA, Thompson WD (2006) Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract. BMJ 333:1293–1294PubMedGoogle Scholar
  44. Fleming T (ed) (2000) PDR for herbal medicines. Medical Economics Company, MontvaleGoogle Scholar
  45. Forslund T, Fyhrquist F, Froseth B, Tikkanen I (1989) Effects of licorice on plasma atrial natriuretic peptide in healthy volunteers. J Intern Med 225:95–99PubMedGoogle Scholar
  46. Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K et al (1999) Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220:225–228PubMedGoogle Scholar
  47. Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG et al (2009) Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 113:5927–5937PubMedGoogle Scholar
  48. Gorter RW, van Wiley M, Stoss M, Wollina U (1998) Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Am J Health Ther 5:181–187Google Scholar
  49. Grossarth-Maticek R, Kiene H, Baumgartner S, Ziegler R (2001) Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 7:57–78PubMedGoogle Scholar
  50. Gururaj AE, Belakavadi M, Venkatesh DA, Marmé D, Salimath BP (2002) Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Bioph Res Co 297:934–942Google Scholar
  51. Hata M, Sasaki E, Ota M, Fujimoto K, Yajima J, Shichida T et al (1997) Allergic contact dermatitis from curcumin (turmeric). Contact Dermatitis 36:107–108PubMedGoogle Scholar
  52. Hu Z, Yang X, Ho PCL, Chan SY, Heng PWS, Chan E et al (2005) Herb-drug interactions. Drugs 65:1239–1282PubMedGoogle Scholar
  53. Javvadi P, Segan AT, Tuttle SW, Koumenis C (2008) The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73:1491–1501PubMedGoogle Scholar
  54. Jeong HG, You HJ, Park SJ, Moon AR, Chung YC, Kang SK et al (2002) Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol Res 46:221–227PubMedGoogle Scholar
  55. Jhanwar YS, Divgi C (2005) Current status of therapy of solid tumors. J Nucl Med 46:141–150Google Scholar
  56. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS et al (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during promotion/progression stage of colon cancer. Cancer Res 59:597–601PubMedGoogle Scholar
  57. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC (1994) Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 54:2015s–2024sPubMedGoogle Scholar
  58. Kent UM, Aviram M, Rosenblat M, Hollenberg PF (2002) The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Drug Metab Dispos 30:709–715PubMedGoogle Scholar
  59. Kienle GS, Glockmann A, Schink M, Kiene HJ (2009) Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. Exp Clin Cancer Res 28:79Google Scholar
  60. Konić-Ristić A, Šavikin K, Zdunić G, Janković T, Juranić Z, Menković N, Stanković I (2011) Biological activity and chemical composition of different berry juices. Food Chem 125:1412–1417Google Scholar
  61. Koppikar SJ, Choudhari AS, Suryavanshi SA, Kumari S, Chattopadhyay S, Kaul-Ghanekar R (2010) Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer 10:210PubMedGoogle Scholar
  62. Kundaković T, Stanojković T, Juranić Z, Kovacević N (2005) Cytotoxic and antioxidant activity of Achillea alexandri-regis. Pharmazie 60:319–320PubMedGoogle Scholar
  63. Kundaković T, Stanojković T, Juranić Z, Kovacević N (2006) Cytotoxicity in vitro of naphthazarin derivatives from Onosma arenaria. Phytother Res 20:602–604PubMedGoogle Scholar
  64. Kundu JK, Surh YJ (2004) Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets. Mutat Res 555:65–80PubMedGoogle Scholar
  65. Lin SH, Yang SS, Chau T, Halperin ML (2003) An unusual cause of hypokalemic paralysis: chronic licorice ingestion. Am J Med Sci 325:153–156PubMedGoogle Scholar
  66. Maier G, Fiebig HH (2002) Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Anticancer Drugs 13:373–379PubMedGoogle Scholar
  67. Miner TJ (2005) Palliative surgery for advanced cancer: lessons learned in patient selection and outcome assessment. Am J Clin Oncol 28:411–414PubMedGoogle Scholar
  68. Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N et al (2000) Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275:10405–10412PubMedGoogle Scholar
  69. Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S et al (2006) Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther 316:1369–1377PubMedGoogle Scholar
  70. Nabekura T, Yamaki T, Ueno K, Kitagawa S (2008) Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 62:867–873PubMedGoogle Scholar
  71. Noguchi M, Yokoyama M, Watanabe S, Uchiyama M, Nakao Y, Hara K et al (2006) Inhibitory effect of the tea polyphenol, (−)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines. Cancer Lett 234:135–142PubMedGoogle Scholar
  72. Patel D, Shukla S, Gupta S (2007) Apigenin and cancer chemoprevention: progress, potential and promise (Review). Int J Oncol 30:233–245PubMedGoogle Scholar
  73. Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J (2001) The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 33:125–147PubMedGoogle Scholar
  74. Portalupi E (1995) Neoadjuvant treatment in HPV-related CIN with Mistletoe preparation (Iscador). Dissertation Universität Pavia 1991/1992Google Scholar
  75. Prucksunand C, Indrasukhsri B, Leethochawalit M, Hungspreugs K (2001) Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. Southeast Asian J Trop Med Public Health 32:208–215PubMedGoogle Scholar
  76. Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G et al (2000) Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 20:2653–2658PubMedGoogle Scholar
  77. Robinson DM (2003) Anaphylaxis to turmeric. J Allergy Clin 111:S100Google Scholar
  78. Rosell S, Samuelsson G (1966) Effect of mistletoe viscotoxin and phoratoxin on blood circulation. Toxicon 4:107–110PubMedGoogle Scholar
  79. Russo S, Mastropasqua M, Mosetti MA, Persegani C, Paggi A (2000) Low doses of licorice can induce hypertension encephalopathy. Am J Nephrol 20:145–148PubMedGoogle Scholar
  80. Sadeghi-Aliabadi H, Ghasemic N, Fatahia A (2006) Cytotoxic effects of Iranian mistletoe extract on a panel of cancer cells. Iranian J Pharm Sci 2:157–162Google Scholar
  81. Sagar SM, Yance D, Wong RK (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol 13:14–26PubMedGoogle Scholar
  82. Samuelsson G (1966) Screening of plants of the family Loranthaceae for toxic proteins. Acta Pharm Suec 3:353–362PubMedGoogle Scholar
  83. Sasieni P (2006) Chemoprevention of cervical cancer. Best Pract Res Clin Obstet Gynaecol 20:295–305PubMedGoogle Scholar
  84. Šavikin K, Zdunić G, Janković T, Stanojković T, Juranić Z, Menković N (2009) In vitro cytotoxic and antioxidative activity of Cornus mas and Cotinus coggygria. Nat Prod Res 23:1731–1739PubMedGoogle Scholar
  85. Schulz V, Hansel R, Tyler V (2001) Rational phytotherapy: a physician’s guide. Springer, New YorkGoogle Scholar
  86. Sen S, Sharma H, Singh N (2005) Curcumin enhances vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 331:1245–1252PubMedGoogle Scholar
  87. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM et al (2001) Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7:1894–1900PubMedGoogle Scholar
  88. Shin SC, Choi JS (2009) Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs 20:584–588PubMedGoogle Scholar
  89. Shintani S, Murase H, Tsukagoshi H, Shiigai T (1992) Glycyrrhizin (licorice)-induced hypokalemic myopathy. Eur Neurol 32:44–51PubMedGoogle Scholar
  90. Sigurjonsdottir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S (2001) Licorice-induced rise in blood pressure: a linear dose-response relation- ship. J Hum Hypertens 15:549–552PubMedGoogle Scholar
  91. Singh S, Aggarwal BB (1995) Activation of transcription factor NF-κB is suppressed by curcumin (diferuloyl-methane). J Biol Chem 270:24995–25000PubMedGoogle Scholar
  92. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ (2002) Dietary curcumin inhibits chemotheraphy induced apoptosis in models of human breast cancer. Cancer Res 62:3868–3875PubMedGoogle Scholar
  93. Stanojković TP, Konić-Ristić A, Juranić ZD, Savikin K, Zdunić G, Menković N et al (2010) Cytotoxic and cell cycle effects induced by two herbal extracts on human cervix carcinoma and human breast cancer cell lines. J Med Food 13:291–297PubMedGoogle Scholar
  94. Steinmetz KA, Potter JD (1996) Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96:1027–1039PubMedGoogle Scholar
  95. Stević T, Šavikin K, Zdunić G, Stanojković T, Juranić Z, Janković T et al (2010) Antioxidant, cytotoxic, and antimicrobial activity of Alnus incana (L.) ssp. incana Moench and A. viridis (Chaix) DC ssp. viridis extracts. J Med Food 13:700–704PubMedGoogle Scholar
  96. Stirpe F, Legg RF, Onyon LJ, Ziska P, Franz H (1980) Inhibition of protein synthesis by a toxic lectin from Viscum album L. (mistletoe). Biochem J 190:843–845PubMedGoogle Scholar
  97. Sugiyama T, Sadzuka Y (2004) Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett 212:177–184PubMedGoogle Scholar
  98. Takara K, Horibe S, Obata Y, Yoshikawa E, Ohnishi N, Yokoyama T (2005) Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells. Biol Pharm Bull 28:138–142PubMedGoogle Scholar
  99. Taylor JR, Wilt VM (1999) Probable antagonism of warfarin by green tea. Ann Pharmacother 33:426–428PubMedGoogle Scholar
  100. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK (1998) Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9:305–312PubMedGoogle Scholar
  101. Thani W, Vallisuta O, Siripong P, Ruangwises N (2010) Anti-proliferative and antioxidative activities of Thai noni/Yor (Morinda citrifolia Linn.) leaf extract. Southeast Asian J Trop Med Public Health 41:482–489PubMedGoogle Scholar
  102. Tierney B, Westin SN, Schlumbrecht MP, Ramirez PT (2010) Early cervical neoplasia: advances in screening and treatment modalities. Clin Adv Hemat Oncol 8:8Google Scholar
  103. Trifunović S, Vajs V, Juranić Z, Žižak Ž, Tešević V, Macura S et al (2006) Cytotoxic constituents of Achillea clavennae from Montenegro. Phytochemistry 67:887–893PubMedGoogle Scholar
  104. van-den Bosch AE, van-der Klooster JM, Zuidgeest DM, Ouwendijk RJ, Dees A (2005) Severe hypokalaemic paralysis and rhabdomyolysis due to ingestion of liquorice. Neth J Med 63:146–148PubMedGoogle Scholar
  105. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedGoogle Scholar
  106. Vizcaino PA, Moreno V, Bosch XF, Munoz N, Barros-Dios XM, Parkin MD (1998) International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75:536–545PubMedGoogle Scholar
  107. Vučković I, Lj V, Stešević D, Radulović S, Lazić M, Milosavljević S (2010) Cytotoxic guaianolide from Anthemis segetalis (Asteraceae). Phytother Res 24:225–227PubMedGoogle Scholar
  108. Wang Y, Zhang H, Holmgren A, Tian W, Zhong L (2008) Inhibitory effect of green tea extract and (−)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Oncol Rep 20:1479–1487PubMedGoogle Scholar
  109. Wu Z, Wu LJ, Li LH, Tashiro S, Onodera S, Ikejima T (2004) Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis. J Asian Nat Prod Res 6:155–166PubMedGoogle Scholar
  110. Xaio P (1983) Recent developments on medicinal plants in China. J Ethnopharmacol 7:95–109PubMedGoogle Scholar
  111. Yu M, Deng PX, Qi C, Deng B, Zhao ZZ, Wong V et al (2009) Adjuvant phytotherapy in the treatment of cervical cancer: a systematic review and meta-analysis. J Altern Complement Med 15:1347–1353Google Scholar
  112. Zhang W, Tan TM, Lim LY (2007) Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 35:110–115PubMedGoogle Scholar
  113. Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton J (2003) Interactions of herbs with cytochrome P450. Drug Metab Rev 35:35–98PubMedGoogle Scholar
  114. Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL et al (2002) Radiosensitizing and antiproliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 175:165–173PubMedGoogle Scholar
  115. Zou C, Liu H, Feugang JM, Hao Z, Chow HH, Garcia F (2010) Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer 20:617–624PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Tatjana Stanojković
    • 1
  • Aleksandra Konić-Ristić
    • 2
  • Teodora Janković
    • 3
  • Gordana Zdunić
    • 3
  • Katarina Šavikin
    • 3
  1. 1.Institute of Oncology and Radiology of SerbiaBelgradeSerbia
  2. 2.Department of Nutrition and MetabolismInstitute for Medical ResearchBelgradeSerbia
  3. 3.Institute for Medicinal Plants ResearchBelgradeSerbia

Personalised recommendations